SCHEMBL21333280

SCHEMBL21333280

Cc1c(C(=O)Cn2cc(Br)ccc2=O)cnn1Cc1cccnc1

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 2/20 0.39
S1PR2 O95136 1/20 0.38
FPR1 P21462 1/20 0.38
FPR2 P25090 1/20 0.38
KMT2A Q03164 2/20 0.37
SMN1; SMN2 Q16637 1/20 0.37
PPARG P37231 1/20 0.37
RXFP1 Q9HBX9 1/20 0.37
NCOR2 Q9Y618 1/20 0.37
ALDH1A1 P00352 2/20 0.36
CNR1 P21554 1/20 0.36
CNR2 P34972 1/20 0.36
HDAC3 O15379 1/20 0.36
HDAC4 P56524 1/20 0.36
HDAC1 Q13547 1/20 0.36
HDAC7 Q8WUI4 1/20 0.36
HDAC2 Q92769 1/20 0.36
HDAC10 Q969S8 1/20 0.36
HDAC11 Q96DB2 1/20 0.36
HDAC8 Q9BY41 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL21332946 0.90 S1PR2 (0.47) KDM4ES1PR2KMT2ASMN1; SMN2ALDH1A1
SCHEMBL21333291 0.85 KDM4E (0.37) KDM4ES1PR2KMT2ASMN1; SMN2ALDH1A1
SCHEMBL21332885 0.84 PTGDR2 (0.41) KDM4ES1PR2KMT2ASMN1; SMN2ALDH1A1
SCHEMBL21333435 0.83 KMT2A (0.42) S1PR2KMT2ASMN1; SMN2HDAC1HDAC6
SCHEMBL21333289 0.83 S1PR2 (0.43) KDM4ES1PR2KMT2ASMN1; SMN2ALDH1A1
SCHEMBL21333078 0.82 CREBBP (0.43) S1PR2KMT2ASMN1; SMN2RXFP1CNR2
SCHEMBL21332960 0.81 KMT2A (0.44) KDM4ES1PR2KMT2ASMN1; SMN2MAPT
SCHEMBL31675001 0.81 KMT2A (0.44) KDM4ES1PR2KMT2ASMN1; SMN2MAPT
SCHEMBL21333022 0.79 ALDH1A1 (0.45) KDM4EKMT2ASMN1; SMN2ALDH1A1PKM
SCHEMBL21332978 0.77 S1PR2 (0.47) KDM4ES1PR2KMT2ASMN1; SMN2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3762377-B1 PYRIDINONE- AND PYRIDAZINONE-BASED COMPOUNDS AND MEDICAL USES THEREOF UNIV CORNELL (US) 2025-08-20 EP disclosed
US-11964960-B2 Pyridinone- and pyridazinone-based compounds and uses thereof CORNELL UNIVERSITY (US) 2024-04-23 US disclosed
EP-3762377-A1 PYRIDINONE- AND PYRIDAZINONE-BASED COMPOUNDS AND MEDICAL USES THEREOF Cook, Timothy, H. (US) 2021-01-13 EP disclosed
US-20200407339-A1 PYRIDINONE- AND PYRIDAZINONE-BASED COMPOUNDS AND USES THEREOF TRI-INSTITUTIONAL THERAPEUTICS DISCOVERY INSTITUTE 2020-12-31 US disclosed
US-20200407339-A1 PYRIDINONE- AND PYRIDAZINONE-BASED COMPOUNDS AND USES THEREOF TRI-INSTITUTIONAL THERAPEUTICS DISCOVERY INSTITUTE 2020-12-31 US disclosed
WO-2019173790-A1 PYRIDINONE- AND PYRIDAZINONE-BASED COMPOUNDS AND MEDICAL USES THEREOF HLA TIMOTHY (US) 2019-09-12 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200407339-A1 PYRIDINONE- AND PYRIDAZINONE-BASED COMPOUNDS AND USES THEREOF PTGER1, LOXL1, COL1A1 KDM4E 2671/4885S1PR2 601/4885FPR1 156/4885
US-11964960-B2 Pyridinone- and pyridazinone-based compounds and uses thereof PTGER1, LOXL1, COL1A1 KDM4E 2671/4885S1PR2 601/4885FPR1 156/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.